Literature DB >> 539599

Combined effects of ticarcillin and cefazolin on blood coagulation and platelet function.

E A Natelson, W T Siebert, T W Williams, M W Bradshaw.   

Abstract

Combined intravenous infusions of ticarcillin and cefazolin given to normal volunteers resulted in a functional platelet defect which appeared to be determined primarily by the dose and duration of treatment with the penicillin component. No effect on soluble blood coagulation factors was evident. Acute administration of corticosteroids did not influence the prolonged bleeding times induced by extended ticarcillin infusions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 539599     DOI: 10.1097/00000441-197911000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Haemostasis during treatment with ciprofloxacin.

Authors:  M Ziemen; P M Shah; K Breddin
Journal:  Infection       Date:  1988       Impact factor: 3.553

2.  Effects of apalcillin on platelet function in normal volunteers.

Authors:  L O Gentry; B A Wood; E A Natelson
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

Review 3.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

4.  [Hemostatic parameters influenced by imipenem/cilastatin].

Authors:  M Ziemen; P M Shah; M Henkel-Bussmann; H K Breddin
Journal:  Infection       Date:  1986       Impact factor: 3.553

5.  In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.

Authors:  R Snepar; G Poporad; J Romano; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  Effects of sodium piperacillin on platelet function in normal volunteers.

Authors:  L O Gentry; J G Jemsek; E A Natelson
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.